Skip to main content
. 2019 Oct 10;14(10):e0223470. doi: 10.1371/journal.pone.0223470

Fig 2. Plasma cfDNA levels are significantly elevated in cancer patients.

Fig 2

Plasma cell-free DNA (cfDNA) was isolated from breast (n = 26) and ovarian cancer (n = 64) patients with various stages and undergoing treatment. Female subjects (n = 50) from healthy individuals of a similar age were selected as controls for breast and ovarian cancer patients. Separate cfDNA comparisons wre made between healthy female controls and the cancers patients by Wilcoxon rank sum test. Highly significant differences (***) were observed between cfDNA levels measured by Qubit fluorometer (ng/ml) of healthy females and breast cancer patients (p = 6.278e-07) and healthy females and ovarian cancer patients (p = 2.708e-11).